Works matching IS 15228517 AND DT 2020 AND VI 22 AND IP 5
Results: 20
Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 613, doi. 10.1093/neuonc/noz235
- By:
- Publication type:
- Article
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 705, doi. 10.1093/neuonc/noz232
- By:
- Publication type:
- Article
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 694, doi. 10.1093/neuonc/noz231
- By:
- Publication type:
- Article
Anti–PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 639, doi. 10.1093/neuonc/noz226
- By:
- Publication type:
- Article
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 684, doi. 10.1093/neuonc/noz222
- By:
- Publication type:
- Article
A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 675, doi. 10.1093/neuonc/noz208
- By:
- Publication type:
- Article
Risk factors for the development of epilepsy in patients with brain metastases.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 718, doi. 10.1093/neuonc/noz172
- By:
- Publication type:
- Article
Celebrating SNO's official journal, Neuro-Oncology.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 585, doi. 10.1093/neuonc/noaa070
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 598, doi. 10.1093/neuonc/noaa069
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 737, doi. 10.1093/neuonc/noaa068
- Publication type:
- Article
Way to Go/No-Go!
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 596, doi. 10.1093/neuonc/noaa061
- By:
- Publication type:
- Article
Astrocytes: new stars in the medulloblastoma firmament.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 587, doi. 10.1093/neuonc/noaa057
- By:
- Publication type:
- Article
Quantification of leptomeningeal metastases from solid tumors remains a challenging issue.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 592, doi. 10.1093/neuonc/noaa056
- By:
- Publication type:
- Article
A troublesome burden, the amplification of EGFR in glioblastoma!
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 594, doi. 10.1093/neuonc/noaa055
- By:
- Publication type:
- Article
Reply to Letter to the Editor.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 734, doi. 10.1093/neuonc/noaa037
- By:
- Publication type:
- Article
A validated prognostic nomogram for patients with newly diagnosed lower-grade gliomas in a large-scale Asian cohort.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 729, doi. 10.1093/neuonc/noaa027
- By:
- Publication type:
- Article
Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 590, doi. 10.1093/neuonc/noaa018
- By:
- Publication type:
- Article
Comment on "GRP94 promotes brain metastasis by engaging pro-survival autophagy".
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 732, doi. 10.1093/neuonc/noaa017
- By:
- Publication type:
- Article
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 601, doi. 10.1093/neuonc/noaa015
- By:
- Publication type:
- Article
Retraction notice: Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 736, doi. 10.1093/neuonc/noaa012
- By:
- Publication type:
- Article